Together against cancer

Newsletter October 2020

  • New webinar Preclinical Evaluation of Anti-metastatic Drug Candidates using a Next-Generation Chicken Embryo Model
  • The latest publication led by Dr. Anna Halama, Assistant Professor of Research in Physiology & Biophysics
  • R&D Booster project: a 900k€ project for deepening our understanding of cancer mechanisms and other diseases
  • FAQ: Can experiments to study metastasis be conducted on Inovotion's model?

Read more

pipette

Newsletter July 2020

  • Webinar: how to optimize in vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates
  • New publication: Inhibition of patched drug efflux increases vemurafenib effectiveness against resistant brafv600e melanoma 
  • Free webinar: combination approach: a breakthrough in vivo model for high-value identification of oncology candidates
  • New standardised cell lines
  • Faq: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Read more

molecules

Newsletter December 2019

  • Inovotion is showcasing its technology via the NC3Rs’ CRACK IT Solutions partnering programme.
  • Jean Viallet, INOVOTION’s CEO and founder, invited to testify on technology transfer, met Frédérique Vidal, French Minister for Advanced Education, Research and Innovation
  • Chick Embryo Chorioallantoic Membrane: a suitable and easy-to-use model for Photodynamic Therapies. An article from the University of Coimbra
  • New standardized cell lines
  • FAQ: Is the chicken embryo model considered animal testing? Do you need to address ethical regulations to perform studies on the chicken embryo model?

Read more

neurone

Newsletter May 2019

  • New cancer model for in vivo efficacy evaluation in the chicken embryo model: effect of cytarabine on the acute myeloid leukemia (aml) cell line mv4-11
  • A real in vivo model without regulatory constraints.
  • Presentation by jean viallet, phd, inovotion’s founder, on anti-pd-1/anti-pd-l1 therapies at the meet2win conference.
  • Ais 2019: inovotion will give a talk and introduce latest developments in in vivo efficacy and safety screening.
  • Latest developed cell lines
  • Events – where to meet us

Read more

blocs

Newsletter February 2019

  • Early in vivo evaluation assays for immune-modulation of anti-PD-1 / anti-PD-L1 based combinations.
  • More than 40 cell lines and 17 reference compounds tested and ready to use for efficacy assays
  • Publication featuring INOVOTION’s platform: Genoscience Pharma evaluated their most advanced compound, GNS561, with the chick embryo model
  • Events – Where to meet us

Read more

Register for our Newsletter